US 7781584
Dipeptidyl peptidase inhibitors
granted A61PA61P13/08A61P13/12
Quick answer
US patent 7781584 (Dipeptidyl peptidase inhibitors) held by Takeda Pharmaceutical Company Limited expires Mon Aug 19 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Aug 24 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 19 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 4
- CPC classes
- A61P, A61P13/08, A61P13/12, A61P15/08, A61P15/16